Evaheart Overview

  • Founded

  • 2003

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 14

Employees
  • Latest Deal Type

  • Later Stage VC

  • Investors

  • 3

Evaheart General Information

Description

Developer of implantable left ventricular assist systems designed to reduce severe heart failure. The company's heart assists devices are implantable mechanical pumps that are opened-vane designed and hydraulically suspended impeller system to provide flat PQ curve pump performance, enabling patients with heart disease to get support blood flow in the time of severe heart failure.

Contact Information

Website
www.evaheart-usa.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Monitoring Equipment
Parent Company
Sun Medical Technology Research
Primary Office
  • 4900 Fournace PI
  • Suite 222
  • Houston, TX 77401
  • United States
+1 (713) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Evaheart Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 01-Sep-2021 00.00 Completed Generating Revenue
4. Corporate 26-Sep-2019 00.00 00.00 Completed Generating Revenue
3. Accelerator/Incubator 03-Jan-2017 Completed Generating Revenue
2. Merger/Acquisition 21-Jan-2011 $7.5M Completed Generating Revenue
1. Joint Venture 01-Apr-2009 $7.5M $7.5M 000.00 Completed Generating Revenue
To view Evaheart’s complete valuation and funding history, request access »

Evaheart Patents

  • 5

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Evaheart Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3906068-A4 Occlusion apparatus for inflow conduit Pending 31-Dec-2018 0000000000 0
US-20210402167-A1 Occlusion apparatus for inflow conduit Pending 31-Dec-2018 0000000000
EP-3906068-A1 Occlusion apparatus for inflow conduit Pending 31-Dec-2018 0000000000
US-D929576-S1 Cannula Active 24-Jul-2018 0
US-D951435-S1 Cannula Active 24-Jul-2018 0
To view Evaheart’s complete patent history, request access »

Evaheart Executive Team (7)

Name Title Board Seat Contact Info
Tadashi Motomura MD Co-Founder, President & Chief Executive Officer
Masae Cameron Co-Founder, Chief Financial Officer & Director of Global Business Development
Robert Benkowski Chief Technology Officer
You’re viewing 3 of 7 executive team members. Get the full list »

Evaheart Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Evaheart Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Asahi Kasei Corporation Majority 000 0000 000000 0
To view Evaheart’s complete investors history, request access »

Ready to get started?

Request a free trial